Skip to content
Study details
Enrolling now

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

University of North Carolina, Chapel Hill
NCT IDNCT05282277ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

103

Study length

about 4.7 years

Ages

45–55

Sex

Female only

Locations

1 site in NC

About this study

Researchers are testing whether estradiol, a hormone, affects brain function in women experiencing anhedonia (loss of interest), depression, or psychosis. The trial will use imaging techniques to see how estradiol impacts the brain's response to rewards.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Matching Placebo Patch
  • 2.Take Micronized Progesterone
  • 3.Take Raclopride C11
  • +1 more
PhasePhase 4
DrugMicronized Progesterone
Routetransdermal

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low14%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug classes

Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Progestational Hormone Receptor Agonists), estradiol

Drug routes

transdermal, oral (Oral Capsule), oral (Oral Tablet)

Endpoints

Secondary: Changes in PO Psychosis Symptoms following Estradiol Administration Using the BPRS

Body systems

Psychiatry / Mental Health